BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; and oral diabetic drugs.BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
Research context
Bioton S.A. appears in PyInvesting’s Warsaw Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- PLN
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Bioton S.A. is currently in a long term uptrend where the price is trading 4.9% above its 200 day moving average.
Bioton S.A.'s total revenue sank by 70.6% to $43M since the same quarter in the previous year.
Its net income has increased by 102.7% to $2M since the same quarter in the previous year.
Finally, its free cash flow grew by 534.7% to $25M since the same quarter in the previous year.
Based on the above factors, Bioton S.A. gets an overall score of 3/5.